Your browser doesn't support javascript.
loading
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC.
Javitt, Aaron; Shmueli, Merav D; Kramer, Matthias P; Kolodziejczyk, Aleksandra A; Cohen, Ivan J; Radomir, Lihi; Sheban, Daoud; Kamer, Iris; Litchfield, Kevin; Bab-Dinitz, Elizabeta; Zadok, Oranit; Neiens, Vanessa; Ulman, Adi; Wolf-Levy, Hila; Eisenberg-Lerner, Avital; Kacen, Assaf; Alon, Michal; Rêgo, Ana Toste; Stacher-Priehse, Elvira; Lindner, Michael; Koch, Ina; Bar, Jair; Swanton, Charles; Samuels, Yardena; Levin, Yishai; da Fonseca, Paula C A; Elinav, Eran; Friedman, Nir; Meiners, Silke; Merbl, Yifat.
Affiliation
  • Javitt A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Shmueli MD; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. merav.shmueli@weizmann.ac.il.
  • Kramer MP; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Kolodziejczyk AA; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Cohen IJ; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Radomir L; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Sheban D; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Kamer I; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Litchfield K; UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Bab-Dinitz E; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Zadok O; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Neiens V; Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum Muenchen, Munich, Germany.
  • Ulman A; Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Wolf-Levy H; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Eisenberg-Lerner A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Kacen A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Alon M; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Rêgo AT; Department of Molecular and Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Stacher-Priehse E; MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Lindner M; Asklepios Lung Clinic Munich-Gauting, Gauting, Germany.
  • Koch I; Asklepios Lung Clinic Munich-Gauting, Gauting, Germany.
  • Bar J; Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Swanton C; Asklepios Lung Clinic Munich-Gauting, Gauting, Germany.
  • Samuels Y; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Levin Y; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • da Fonseca PCA; UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Elinav E; Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Friedman N; de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
  • Meiners S; Department of Molecular and Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Merbl Y; School of Molecular Biosciences, University of Glasgow, Glasgow, UK.
Nat Cancer ; 4(5): 629-647, 2023 05.
Article in En | MEDLINE | ID: mdl-37217651
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Year: 2023 Type: Article